Form 4: CEL SCI Director Robert Watson Increases Stake with Stock Purchase

Sentiment:

Insider Transaction Report 29 July 2025 7:56 AM

CEL SCI Corporation Director Robert Watson acquired 2,919 shares of the company's common stock, increasing his direct beneficial ownership.

Better than expectedThe purchase of additional shares by a director suggests confidence in the company's prospects and valuation, which is generally viewed as a positive signal by the market.

Summary

Director Robert Watson purchased 2,919 shares of CEL SCI Corp common stock.
The transaction occurred on July 25, 2025.
The shares were acquired at a price of $6.85 per share.
The purchase was for restricted stock, bought directly from the company.
The purchase price was based on the closing price of July 24, 2025.
Following this transaction, Mr. Watson directly beneficially owns 3,733 shares of common stock.

Sentiment

Score: 8

Explanation: The sentiment is positive as a key insider (Director) has increased their stake in the company, signaling confidence in its future performance and valuation.

Positives

Director Robert Watson increased his direct ownership in CEL SCI Corp, indicating confidence in the company's future prospects.
The purchase of 2,919 shares of restricted stock at $6.85 per share demonstrates a personal investment by a key insider.

Future Outlook

Industry Context

This filing details an insider transaction, specifically a director's purchase of company stock, which is a common occurrence in the financial markets and often interpreted as a signal of management's confidence in the company's valuation and future performance. It does not provide broader industry trends or competitive analysis.

Related Party Transactions

Director Robert Watson purchased 2,919 shares of restricted stock directly from CEL SCI Corp.

Stakeholder Impact

Shareholders: Insider buying can be perceived as a positive indicator, potentially boosting investor confidence and signaling alignment of interests between management and shareholders.

Key Dates

Date	Description
07/24/2025	Date of the most recent closing price used for the stock purchase.
07/25/2025	Date of the common stock acquisition transaction.
07/29/2025	Date the Form 4 was signed by the reporting person.

Recommendation

buy

The director's decision to increase his personal investment in CEL SCI Corp by purchasing additional shares is a strong vote of confidence in the company's future and its current valuation, suggesting potential upside for investors.

Keywords

CEL SCI, CVM, insider trading, stock purchase, director, beneficial ownership, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.